HbA1c实验室检验的全球市场:成长,未来展望,竞争分析 (2025年~2033年)
市场调查报告书
商品编码
1645222

HbA1c实验室检验的全球市场:成长,未来展望,竞争分析 (2025年~2033年)

HbA1c Laboratory Testing Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033

出版日期: | 出版商: Acute Market Reports | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

在医学诊断领域,HbA1c 实验室检测发挥着至关重要的作用,尤其是在糖尿病管理和监测中。 HbA1c 测试提供三个月的平均血糖水平,为临床医生提供有关患者血糖控制情况的宝贵见解。预计 2025 年至 2033 年期间 HbA1c 实验室检测市场复合年增长率为 5.5%。这是由于技术进步影响的多种因素造成的,包括全球健康趋势和快速的技术发展。

推动因素:全球糖尿病盛行率上升

随着糖尿病成为全球主要的公共卫生问题,对有效监测工具的需求大幅增加,包括 HbA1c 实验室检查。例如,世界卫生组织(WHO)报告称,过去十年来全球糖尿病盛行率稳步上升,显示这一健康困境的严重性和紧迫性。因此,HbA1c 检测已成为医疗领域不可或缺的检测项目。定期进行 HbA1c 检测可及时介入、调整药物治疗方案,并有助于预防糖尿病相关併发症,如神经病变、肾病变和视网膜病变,进而改善患者的治疗效果。

机会:将人工智慧和机器学习融入诊断领域

人工智慧 (AI) 和机器学习 (ML) 领域的技术进步正在为 HbA1c 实验室测试市场开闢新的视野。人们越来越有兴趣使用人工智慧演算法根据 HbA1c 结果和其他患者数据来预测糖尿病进展和相关併发症。例如,一些医疗和科技新创公司以及成熟的诊断实验室正在探索如何整合人工智慧驱动的预测分析,以便从 HbA1c 测试结果中提供更多可操作的见解。这不仅增强了测试的临床实用性,而且增加了一层预防护理,帮助临床医生主动管理患者。

阻碍因素:低收入地区的检测成本高且机会有限

儘管 HbA1c 测试的重要性毋庸置疑,但成本对许多人来说仍然是一个重大障碍。在某些地区,特别是中低收入国家,定期进行 HbA1c 检测的费用过高。此外,一些保险计划不包括 HbA1c 检测,增加了患者的自付费用。此外,必要的基础设施(包括先进的实验室和熟练的技术人员)并非普遍存在,这可能会进一步限制检测的机会。国际糖尿病联盟的一份报告也明显指出了医疗保健基础设施的差异,该报告强调了已开发国家和发展中国家在获得糖尿病治疗方面的鲜明对比。

课题:变异性与标准化问题

HbA1c 测试最迫切的问题是测试结果的多变性。不同的实验室使用不同的测试方法,这可能会促使结果略有不同。这带来了课题,尤其是当患者更换医疗保健提供者并且临床医生依赖多个实验室的结果时。美国糖尿病协会先前曾强调对 HbA1c 检测标准化的担忧,并强调需要在全球范围内制定一致的检测协议以确保统一性和可靠性。

依技术分析

2024 年,主导 HbA1c 实验室检测市场的技术可能会细分为多个类别。离子交换高效液相层析法 (HPLC) 由于其准确性、可重复性和稳健性已成为创收最高的技术。它能够准确地检测出 HbA1c 水平的细微波动,从而赢得了世界各地临床医生的支持。然而,免疫测定显示出最高的复合年增长率,主要是因为其快速的检测能力和大规模筛检的可扩展性,这对于南亚等人口密集的地区至关重要。硼酸亲和色谱法和直接酶测定法虽然不太普及,但在某些临床场景中提供了独特的解决方案。其他技术也补充了市场,满足了特殊需求或服务于具有特定诊断偏好的地区。

最终使用者的分析

诊断实验室将成为 2024 年市场收入的主要贡献者。我们庞大的网路、可用性和 HbA1c 测试专业知识使我们成为许多医疗保健提供者的首选。另一方面,预计收入可观的医院实验室将实现最高的复合年增长率。这一趋势可归因于糖尿病患者数量的增加,以及可确保及时干预的住院检测设施的可用性。其他实体,如研究实验室,也发挥作用,特别是在临床研究和调查方面。

区域分析

按地区划分,由于糖尿病盛行率高、医疗基础设施先进以及患者意识强,预计 2024 年北美将在市场收入方面占据主导地位。然而,预计亚太地区在 2025 年至 2033 年期间的复合年增长率最高。印度和中国等国家的糖尿病人口快速成长,加上医疗支出的增加和诊断设施的出现,可能会进一步推动这一成长。欧洲拥有成熟的医疗保健体系,预计将继续做出重大贡献,而拉丁美洲和非洲儘管在医疗保健的可及性和可负担性方面存在课题,但仍提供了潜在的成长机会。

竞争趋势

竞争格局不断改变。到 2024 年,雅培实验室、Bio-Rad 实验室、罗氏公司、丹纳赫集团、西门子医疗有限公司、赛默飞世尔科技公司、Ortho Clinical Diagnostics、ARKRAY 公司、EKF Diagnostics Holdings plc 和 Meril Life Science Pvt. Ltd. 等主要参与者将凭藉其先进的HPLC 和免疫测定解决方案占据主导地位。这些公司的策略重点是研究、地理扩张以及与诊断和研究组织的合作。从 2025 年到 2033 年,这些领先的公司预计将深入研究 AI 整合和自动化,扩大其在新兴市场的影响力,以满足对快速、可扩展和准确的 HbA1c 检测解决方案的需求。

目录

第1章 序文

  • 分析内容
    • 分析的目的
    • 对象者
    • 主要的提供内容
  • 市场区隔
  • 分析方法
    • 阶段Ⅰ:二次调查
    • 阶段Ⅱ:一次调查
    • 阶段Ⅲ:有学识者检讨
    • 前提条件
    • 所采用的方法

第2章 摘要整理

第3章 HbA1c实验室检验市场:竞争分析

  • 主要供应商的市场定位
  • 供应商所采用的策略
  • 主要的产业策略

第4章 HbA1c实验室检验市场:常量分析和市场动态

  • 简介
  • 全球HbA1c实验室检验市场 (以金额为准,2023~2033年)
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 主要课题
    • 主要的机会
  • 促进因素与阻碍因素的影响分析
  • Seesaw分析
  • 波特的五力分析
    • 供应商电力
    • 买主电力
    • 替代品的威胁
    • 新加入厂商业者的威胁
    • 竞争企业间的敌对关係
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 技术性形势
    • 法律上的形势
    • 社会形势

第5章 HbA1c实验室检验市场:各技术 (2023~2033年)

  • 市场概要
  • 成长·收益分析:2024年 vs 2033年
  • 市场区隔
    • 离子交换高效液相层析 (HPLC)
    • 免疫检测
    • 硼酸affinity层析法
    • 直接酵素化验
    • 其他

第6章 HbA1c实验室检验市场:各终端用户 (2023~2033年)

  • 市场概要
  • 成长·收益分析:2024年 vs 2033年
  • 市场区隔
    • 诊断检验室
    • 医院内检验室
    • 其他 (研究机关等)

第7章 北美的HbA1c实验室检验市场 (2023~2033年)

  • 市场概要
  • HbA1c实验室检验市场:各技术 (2023~2033年)
  • HbA1c实验室检验市场:各终端用户 (2023~2033年)
  • HbA1c实验室检验市场:各地区 (2023~2033年)
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第8章 北美的HbA1c实验室检验市场 (2023~2033年)

  • 市场概要
  • HbA1c实验室检验市场:各技术 (2023~2033年)
  • HbA1c实验室检验市场:各终端用户 (2023~2033年)
  • HbA1c实验室检验市场:各地区 (2023~2033年)
    • 英国·EU各国
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 其他欧洲地区

第9章 亚太地区的HbA1c实验室检验市场 (2023~2033年)

  • 市场概要
  • HbA1c实验室检验市场:各技术 (2023~2033年)
  • HbA1c实验室检验市场:各终端用户 (2023~2033年)
  • HbA1c实验室检验市场:各地区 (2023~2033年)
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区

第10章 南美的HbA1c实验室检验市场 (2023~2033年)

  • 市场概要
  • HbA1c实验室检验市场:各技术 (2023~2033年)
  • HbA1c实验室检验市场:各终端用户 (2023~2033年)
  • HbA1c实验室检验市场:各地区 (2023~2033年)
    • 南美
      • 巴西
      • 墨西哥
      • 其他南美国家地区

第11章 中东·非洲的HbA1c实验室检验市场 (2023~2033年)

  • 市场概要
  • HbA1c实验室检验市场:各技术 (2023~2033年)
  • HbA1c实验室检验市场:各终端用户 (2023~2033年)
  • HbA1c实验室检验市场:各地区 (2023~2033年)
    • 中东·非洲
      • GCC
      • 非洲
      • 其他中东·非洲地区

第12章 企业简介

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics
  • ARKRAY Inc.
  • EKF Diagnostics Holdings plc
  • Meril Life Science Pvt. Ltd.
  • 其他
Product Code: 114-12-24

In the realm of healthcare diagnostics, HbA1c laboratory testing holds a pivotal role, particularly in the context of diabetes management and monitoring. HbA1c tests provide an average blood glucose level over a period of three months, offering clinicians valuable insight into a patient's glycemic control. HbA1c laboratory testing market is estimated to grow at a CAGR of 5.5% from 2025 to 2033, driven by influenced by a myriad of factors ranging from global health trends to rapid technological evolution, influenced by technological advancements.

Driver - The Rising Global Prevalence of Diabetes

With diabetes becoming a significant public health concern worldwide, the demand for effective monitoring tools, including HbA1c laboratory tests, has witnessed a remarkable surge. Evidences highlight the alarming increase in diabetes incidence; for instance, the World Health Organization (WHO) had reported in the past decade about a steady rise in diabetes cases globally, signifying the sheer magnitude and urgency of this health predicament. In line with this, HbA1c tests have become indispensable in medical practice. Regular HbA1c testing allows for timely intervention, adjustment of medication regimens, and has been linked to better patient outcomes by aiding in the prevention of diabetes-related complications such as neuropathy, nephropathy, and retinopathy.

Opportunity - Integration of AI and Machine Learning in Diagnostics

Technological advancements in the realm of artificial intelligence (AI) and machine learning (ML) are opening new horizons for the HbA1c laboratory testing market. There's growing interest in utilizing AI algorithms to predict diabetes progression and related complications based on HbA1c results and other patient data. For example, several healthcare technology startups and established diagnostic labs are exploring ways to integrate AI-driven predictive analytics to offer more actionable insights from HbA1c test results. This not only augments the clinical utility of the test but also adds a layer of preventive care, assisting clinicians in proactive patient management.

Restraint - High Cost of Testing and Limited Accessibility in Low-Income Regions

Despite the undeniable importance of HbA1c tests, the cost remains a considerable barrier for many. In several regions, especially in low-to-middle income countries, the expense associated with regular HbA1c testing can be prohibitive. Moreover, some insurance policies do not cover HbA1c testing, adding to the out-of-pocket costs for patients. Additionally, the requisite infrastructure, including advanced laboratories and skilled technicians, might not be universally available, further restricting test accessibility. Such disparities in healthcare infrastructure were evident in a report by the International Diabetes Federation, which highlighted stark contrasts in diabetes care access between developed and developing nations.

Challenge - Variability and Standardization Concerns

One of the more pressing challenges in the HbA1c testing arena is the potential variability in test results. Different laboratories might use diverse testing methodologies, potentially leading to slight variances in outcomes. This poses a challenge, especially when patients switch healthcare providers or when clinicians rely on results from multiple labs. The American Diabetes Association has previously highlighted concerns regarding the standardization of HbA1c tests and has emphasized the need for globally consistent testing protocols to ensure uniformity and reliability.

Technology Insights

In 2024, the technologies that dominated the HbA1c laboratory testing market could be segregated into multiple categories. Ion Exchange High-Performance Liquid Chromatography (HPLC) emerged as the highest revenue-generating technology, attributed to its precision, repeatability, and robustness. Clinicians globally favored it for its accuracy in detecting even minor variances in HbA1c levels. However, Immunoassay showed the highest CAGR, mainly because of its rapid testing capabilities and its scalability for mass screenings, crucial for populous regions like South Asia. Boronate Affinity Chromatography and Direct Enzymatic Assay, although less prevalent, provided niche solutions in specific clinical scenarios. Other technologies complemented the market, catering to specialized needs or serving regions with specific diagnostic preferences.

End-User Insights

Diagnostic Laboratories in 2024 were the major contributors to the market's revenue. Their vast network, availability, and specialization in HbA1c testing made them the primary choice for many healthcare providers. On the other hand, Hospital-based Laboratories, though generating substantial revenue, were marked with the highest CAGR. This trend could be attributed to the rising in-patient diabetic population and the convenience of in-hospital testing facilities, ensuring prompt intervention. Other entities like Research Laboratories also played their part, especially in the context of clinical research and studies.

Regional Insights

Geographically, North America, in 2024, dominated the market in terms of revenue, backed by a high prevalence of diabetes, advanced healthcare infrastructure, and patient awareness. However, the Asia-Pacific region is expected to display the highest CAGR from 2025 to 2033. Factors such as burgeoning diabetic populations in countries like India and China, coupled with increasing healthcare expenditure and emerging diagnostic facilities, will fuel this growth. Europe, with its mature healthcare systems, will continue to be a significant contributor, while Latin America and Africa will present potential growth opportunities, albeit with challenges related to healthcare access and affordability.

Competitive Trends

The competitive landscape of the HbA1c Laboratory Testing market has always been dynamic. In 2024, key players like Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, ARKRAY, Inc., EKF Diagnostics Holdings plc, Meril Life Science Pvt. Ltd. dominated, leveraging their advanced HPLC and Immunoassay solutions. Their strategies focused on R&D, geographical expansion, and forging partnerships with diagnostic and research labs. As we forecast from 2025 to 2033, it's anticipated that these giants will delve deeper into AI integration and automation, broadening their footprints in emerging markets, and addressing the need for rapid, scalable, and accurate HbA1c testing solutions.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of HbA1c Laboratory Testing market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the HbA1c Laboratory Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Technology
    • Ion Exchange High Performance Liquid Chromatography (HPLC)
    • Immunoassay
    • Boronate Affinity Chromatography
    • Direct Enzymatic Assay
    • Others
  • End-user
    • Diagnostic Laboratories
    • Hospital-based Laboratories
    • Others (Research Laboratories, etc.)
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of HbA1c Laboratory Testing market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the HbA1c Laboratory Testing market?
  • Which is the largest regional market for HbA1c Laboratory Testing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving HbA1c Laboratory Testing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the HbA1c Laboratory Testing market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global HbA1c Laboratory Testing Market
  • 2.2. Global HbA1c Laboratory Testing Market, By Technology, 2024 (US$ Million)
  • 2.3. Global HbA1c Laboratory Testing Market, By End-user, 2024 (US$ Million)
  • 2.4. Global HbA1c Laboratory Testing Market, By Geography, 2024 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2024

3. HbA1c Laboratory Testing Market: Competitive Analysis

  • 3.1. Market Positioning of Key HbA1c Laboratory Testing Market Vendors
  • 3.2. Strategies Adopted by HbA1c Laboratory Testing Market Vendors
  • 3.3. Key Industry Strategies

4. HbA1c Laboratory Testing Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global HbA1c Laboratory Testing Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
    • 5.3.2. Immunoassay
    • 5.3.3. Boronate Affinity Chromatography
    • 5.3.4. Direct Enzymatic Assay
    • 5.3.5. Others

6. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Diagnostic Laboratories
    • 6.3.2. Hospital-based Laboratories
    • 6.3.3. Others (Research Laboratories, etc.)

7. North America HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 7.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 7.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 7.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 7.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 7.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

8. UK and European Union HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 8.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 8.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.4.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.5.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.6.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

9. Asia Pacific HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 9.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 9.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.4.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.5.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.6.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

10. Latin America HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 10.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 10.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 10.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 10.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 10.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

11. Middle East and Africa HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 11.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 11.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 11.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 11.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 11.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Bio-Rad Laboratories, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. F. Hoffmann-La Roche Ltd.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Danaher Corporation
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Siemens Healthcare GmbH
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Thermo Fisher Scientific, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Ortho Clinical Diagnostics
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. ARKRAY, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. EKF Diagnostics Holdings plc
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Meril Life Science Pvt. Ltd.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Others
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 2 Global HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 3 North America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 4 North America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 5 U.S. HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 6 U.S. HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 7 Canada HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 8 Canada HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 9 Rest of North America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 10 Rest of North America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 11 UK and European Union HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 12 UK and European Union HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 13 UK HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 14 UK HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 15 Germany HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 16 Germany HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 17 Spain HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 18 Spain HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 19 Italy HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 20 Italy HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 21 France HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 22 France HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 23 Rest of Europe HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 24 Rest of Europe HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 25 Asia HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 26 Asia HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 27 China HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 28 China HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 29 Japan HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 30 Japan HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 31 India HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 32 India HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 33 Australia HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 34 Australia HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 35 South Korea HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 36 South Korea HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 37 Latin America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 38 Latin America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 39 Brazil HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 40 Brazil HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 41 Mexico HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 42 Mexico HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 43 Rest of Latin America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 44 Rest of Latin America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 45 Middle East and Africa HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 46 Middle East and Africa HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 47 GCC HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 48 GCC HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 49 Africa HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 50 Africa HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 51 Rest of Middle East and Africa HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 52 Rest of Middle East and Africa HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global HbA1c Laboratory Testing Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global HbA1c Laboratory Testing Market: Quality Assurance
  • FIG. 5 Global HbA1c Laboratory Testing Market, By Technology, 2024
  • FIG. 6 Global HbA1c Laboratory Testing Market, By End-user, 2024
  • FIG. 7 Global HbA1c Laboratory Testing Market, By Geography, 2024
  • FIG. 8 Market Geographical Opportunity Matrix - Global HbA1c Laboratory Testing Market, 2024
  • FIG. 9Market Positioning of Key HbA1c Laboratory Testing Market Players, 2024
  • FIG. 10 Global HbA1c Laboratory Testing Market, By Technology, 2024 Vs 2033, %
  • FIG. 11 Global HbA1c Laboratory Testing Market, By End-user, 2024 Vs 2033, %